Experimental Zika vaccine to be tested on humans
PENNSYLVANIA, United States, Tuesday June 21, 2016 —A United States pharmaceutical company and an international DNA vaccine developer have been given the green light to start phase one of a Zika vaccine human trial. In preclinical testing, the synthetic Zika DNA vaccine (GLS-5700) developed by Inovio...